Ambu leadership under scrutiny for communication style

The top management of medical company Ambu is being criticized for not openly discussing the company's challenges.
Photo: PR / Ambu
Photo: PR / Ambu
BY MARKETWIRE, TRANSLATED BY DANIEL PEDERSEN

Danish medical technology company Ambu's top management declines to comment the big stock purchase made by CEO Juan Jose Gonzales upon request from domestic business daily Børsen. Last week, Gonzales bought shares worth USD 4.1m (DKK 26m) in the medtech firm.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading